Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Proteins and Peptides

Alpha 1 Acid Glycoprotein (A1AGP), Immunogen Grade

Product Sizes
1 mg
16-16-010700-IMM-1MG
10 mg
16-16-010700-IMM-10MG
About this Product
SKU:
16-16-010700-IMM
Additional Names:
A1AGP, AGP, AAG, Orosomucoid, ORM|Protein Glycosylation studies, In Vitro Diagnostics, Antisera Production
Buffer:
Salt-free lyophilized solid
CE/IVD:
RUO
Extra Details:
Alpha-1 acid glycoprotein (AGP), a glycoprotein constituting 55-140 mg/dL of plasma, features five N-linked glycan chains comprising 40-45% of its mass, including sialylated bi-/tri-/tetra-antennary structures critical for ligand interactions. Thus contributing to its use as a standard for glycosylation studies. As a major acute-phase reactant, AGP surges up to 5-fold during inflammation, synergizing with haptoglobin to diagnose acute inflammation and differentiate hepatic vs. obstructive jaundice. Its glycosylation profile shifts in pathologies: acute inflammation increases bi-antennary and A Alpha1,3-fucosylated glycans, while chronic states enhance tri-/tetra-antennary fucosylation. AGP binds progesterone 15x more avidly than albumin and complexes with vitamin B-12 when sialic acid-deficient, influencing drug pharmacokinetics and nutrient transport. AGP modulates immunity via TLR-2/4 interactions, exacerbating TLR-2-mediated sepsis mortality while inhibiting LPS-driven NETosis. Dysregulated AGP correlates with rheumatoid arthritis, Waldenstroem macroglobulinemia, and metastatic cancers, where glycoforms alter platelet aggregation and neutrophil adhesion. The AGP:haptoglobin ratio aids in diagnosing bone marrow disorders and hemolytic anemia, reflecting erythropoietic activityTherapeutically, AGP's drug-binding capacity informs personalized dosing for basic drugs (e.g., chlorpromazine), while engineered glycoforms are explored for targeted anti-inflammatory therapies.
Formulation:
Salt-free lyophilized solid
Molecular Weight:
~45,000 Da under Reducing and Non-Reducing Conditions by SDS-PAGE
Physical State:
Lyophilized
Purity:
≥98%
Purification:
Liquid Chromatography Methods
Shipping Conditions:
Blue Ice
Source:
Source human plasma non-reactive for HBsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.
Storage Conditions:
2-8[o]C
Supplier:
Athens Research & Technology Inc.
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Recombinant Proteins